Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
BTB: Dimerix investigates new treatment for COVID-19 complications
Manage episode 330230308 series 3009792
The last few years have been dominated by the global fight against COVID-19 and research efforts continue in search of new treatments and vaccines to save lives.
Melbourne-based Dimerix Bioscience is a clinical-stage biopharmaceutical company investigating a new treatment for respiratory complications as a result of COVID 19 – which was selected for inclusion in the global WHO-endorsed clinical study REMAP-CAP investigating community-acquired pneumonia.
Through MTPConnect’s Biomedical Translation Bridge (BTB) Program, Dimerix was awarded $1 million in MRFF-funding for this COVID-19 related project.
MTPConnect host Caroline Duell catches up with Dr Robert Shepherd, Research & Development Director at Dimerix Bioscience to find out more about this potential new treatment, the benefits and challenges of being part of a unique adaptive clinical trial program and how they managed to manufacture doses for the trial during the pandemic. https://dimerix.com/
Uniquest is a Venture Partner in the BTB Program, and Cecile Francis, Uniquest’s BTB Program Project Manager joins the discussion. https://uniquest.com.au/
171 tập
Manage episode 330230308 series 3009792
The last few years have been dominated by the global fight against COVID-19 and research efforts continue in search of new treatments and vaccines to save lives.
Melbourne-based Dimerix Bioscience is a clinical-stage biopharmaceutical company investigating a new treatment for respiratory complications as a result of COVID 19 – which was selected for inclusion in the global WHO-endorsed clinical study REMAP-CAP investigating community-acquired pneumonia.
Through MTPConnect’s Biomedical Translation Bridge (BTB) Program, Dimerix was awarded $1 million in MRFF-funding for this COVID-19 related project.
MTPConnect host Caroline Duell catches up with Dr Robert Shepherd, Research & Development Director at Dimerix Bioscience to find out more about this potential new treatment, the benefits and challenges of being part of a unique adaptive clinical trial program and how they managed to manufacture doses for the trial during the pandemic. https://dimerix.com/
Uniquest is a Venture Partner in the BTB Program, and Cecile Francis, Uniquest’s BTB Program Project Manager joins the discussion. https://uniquest.com.au/
171 tập
Tất cả các tập
×Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.